During the past decade, American Oncology Partners of Maryland, PA conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 2 clinical trials were completed, i.e. on average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 2 clinical trials were completed. i.e. 5.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "American Oncology Partners of Maryland, PA" #1 sponsor was "Amgen" with 4 trials, followed by "Daiichi Sankyo, Inc." with 3 trials sponsored, "Arcus Biosciences, Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Loxo Oncology, Inc." with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "American Oncology Partners of Maryland, PA" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "American Oncology Partners of Maryland, PA" are "Multiple Myeloma" (5 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Small Lymphocytic Lymphoma" (3 trials), "Breast Cancer" (2 trials) and "Chemotherapy-induced Thrombocytopenia" (2 trials). Many other conditions were trialed in "American Oncology Partners of Maryland, PA" in a lesser frequency.

Most popular intervention types in "American Oncology Partners of Maryland, PA" are "Drug" (33 trials), "Biological" (4 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pomalidomide" (3 trials), "Azacitidine" (2 trials), "Dexamethasone" (2 trials) and "Docetaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "American Oncology Partners of Maryland, PA" are 38 trials for "All" genders.

Currently, there are NaN active trials in "American Oncology Partners of Maryland, PA". undefined are not yet recruiting, 26 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in American Oncology Partners of Maryland, PA, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in American Oncology Partners of Maryland, PA, 12 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".